A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2026

Primary Completion Date

April 30, 2035

Study Completion Date

April 30, 2035

Conditions

Friedreich Ataxia

Interventions

DRUG

Omaveloxolone

Administered as specified in the treatment arm.

Trial Locations (1)

RECRUITING

Evidera, Morrisville